VR Logo

Arena Pharmaceuticals Inc (ARNA) download report


Healthcare | Biotechnology & Pharma Research

Arena Pharmaceuticals Inc (ARNA) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide.

IPO Date: 28-Jul-2000

Pres & CEO: Mr. Amit D. Munshi M.B.A.

Exec. VP & CFO: Ms. Laurie D. Stelzer

Listing: NASDAQ: ARNA

Country: United States

Headquarters: Park City, UT

Website: https://www.arenapharm.com

Key Facts

Market cap: $6,165.32 Mln

Revenue (TTM): $-3.48 Mln

Earnings (TTM): $-616.43 Mln

Cash: $550.47 Mln

Total Debt: $41.21 Mln

Insider's Holding: 0.27%

Liquidity: Low

52 Week range: $45.50 - 100.00

Shares outstanding: 61,659,400

10 Years Aggregate:

  • CFO: $-668.17 Mln
  • EBITDA: $-936.14 Mln
  • Net Profit: $-1,040.33 Mln

Stock Performance

Time Period Arena Pharmaceuticals Inc (ARNA) S&P BSE Sensex* *
YTD7.59-7.86--
1 month6.59-3.75--
3 months11.00-10.80--
1 Year29.741.50--
3 Years29.8610.75--
5 Years47.3411.43--
10 Years18.5711.84--
As on 14-Mar-2022 *As on 06-Jul-2022
Year Arena Pharmaceuticals Inc (ARNA) S&P BSE Sensex S&P BSE Sensex
202120.9721.9921.99
202069.1515.7515.75
201916.6114.3814.38
201814.575.875.87
2017139.2327.9127.91
2016-25.261.951.95
2015-45.24-5.03-5.03